|
Hope the vaccine story is true, but I don’t see how they could know if it works in the wild. They’re doing early Phase I trials, which is my rice bowl, and in those “turn blue” studies they just confirm that the vaccine doesn’t kill healthy, young volunteers. They’ll do antibody titers, sure, but that’s not the goal at this stage. Hope I’m wrong but the consensus I’m hearing is 18 months until there’s a legit vaccine, manufactured in sufficient quantity to be useful.
The only guys with the production capacity and know how to spin up vaccine in quantity are Glaxo, Merck, and Sanofi. I can say now I was on the Glaxo team during the last scare, and they in particular were badly burned by two-faced pols and lost buckets of money, enough to really hurt. I’m sure they’ll do the right thing but the pols have to get their indemnity and funding in line fast. It’s gonna be bloody expensive even if they do it on a break even basis. And then who gets the vaccine first from a Brit company? Or Sanofi in France? Hope Merck's involved.
We may just have to stand and take a beating with this one.
__________________
mugwump
“Klaatu barada nikto”
|